BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 47.23
0.00 (0.00%)
At close: Oct 10, 2025
BridgeBio Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -785.01 | -543.35 | -653.25 | -484.65 | -586.45 | -505.49 | Upgrade |
Depreciation & Amortization | 5.51 | 6.08 | 6.49 | 6.77 | 5.84 | 1.46 | Upgrade |
Stock-Based Compensation | 120.41 | 95.8 | 108.71 | 91.56 | 99.51 | 58.46 | Upgrade |
Other Adjustments | 122.13 | -111.3 | 5.27 | -61.25 | -12.43 | 30.93 | Upgrade |
Change in Receivables | -76.21 | -2.97 | 15.33 | 15.17 | -19.75 | 2.85 | Upgrade |
Changes in Accounts Payable | 9.17 | 1.51 | 2.78 | -0.35 | 2.83 | -0.74 | Upgrade |
Changes in Accrued Expenses | 42.3 | 29.9 | 1.46 | -14.4 | 32.72 | 17.17 | Upgrade |
Changes in Unearned Revenue | -6.79 | 21.88 | -5.44 | 15.26 | - | - | Upgrade |
Changes in Other Operating Activities | -35.77 | -18.28 | -9.08 | 12.4 | -20.2 | -4.34 | Upgrade |
Operating Cash Flow | -655.81 | -520.73 | -527.72 | -419.49 | -497.93 | -399.71 | Upgrade |
Capital Expenditures | -0.78 | -0.93 | -1.31 | -4.82 | -13.25 | -7.52 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 10 | - | - | Upgrade |
Purchases of Intangible Assets | -10.88 | -7.98 | - | -1.5 | -35 | - | Upgrade |
Proceeds from Sale of Intangible Assets | - | - | - | 110 | - | - | Upgrade |
Purchases of Investments | - | -114.08 | -137.26 | -193.06 | -643.28 | -287.85 | Upgrade |
Proceeds from Sale of Investments | - | 158.23 | 193.11 | 532.52 | 477.04 | 249.14 | Upgrade |
Payments for Business Acquisitions | - | - | - | - | 13.65 | - | Upgrade |
Other Investing Activities | - | 25.54 | -0.5 | - | - | -6.76 | Upgrade |
Investing Cash Flow | 20.39 | 60.78 | 54.03 | 453.15 | -200.83 | -52.99 | Upgrade |
Long-Term Debt Issued | - | 906.5 | - | - | 1,188 | 536.96 | Upgrade |
Long-Term Debt Repaid | - | -473.42 | - | -20.49 | -124.12 | - | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | 433.08 | - | -20.49 | 1,064 | 536.96 | Upgrade |
Issuance of Common Stock | 12.56 | 322.9 | 459.21 | 8.08 | 20.46 | 38.22 | Upgrade |
Repurchase of Common Stock | -6.62 | -7.53 | -6.88 | -1.56 | -289.84 | -75.71 | Upgrade |
Net Common Stock Issued (Repurchased) | 5.94 | 315.37 | 452.33 | 6.52 | -269.37 | -37.49 | Upgrade |
Other Financing Activities | - | - | -0.8 | 0.84 | -57.8 | -52.28 | Upgrade |
Financing Cash Flow | 837.01 | 748.46 | 451.54 | -13.13 | 736.45 | 447.19 | Upgrade |
Net Cash Flow | 201.59 | 288.51 | -22.15 | 20.52 | 37.69 | -5.52 | Upgrade |
Beginning Cash & Cash Equivalents | 549.51 | 394.73 | 416.88 | 396.37 | 358.68 | 364.2 | Upgrade |
Ending Cash & Cash Equivalents | 751.1 | 683.24 | 394.73 | 416.88 | 396.37 | 358.68 | Upgrade |
Free Cash Flow | -656.59 | -521.66 | -529.03 | -424.32 | -511.18 | -407.23 | Upgrade |
FCF Margin | -278.44% | -235.09% | -5686.62% | -546.46% | -733.23% | -4936.74% | Upgrade |
Free Cash Flow Per Share | -3.46 | -2.80 | -3.25 | -2.88 | -3.54 | -3.45 | Upgrade |
Levered Free Cash Flow | -762.78 | -62.52 | -648.29 | -486.81 | 509.02 | 94.26 | Upgrade |
Unlevered Free Cash Flow | -642.79 | -554.08 | -612.45 | -497.34 | -568.68 | -468.46 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.